why choose us

First received: April 06, 2023

Clinical Trial: Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Study Status: Completed

Recruit Status: RECRUITING

Condition: Thrombotic Microangiopathies

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Narsoplimab in Pediatric Patients (28 Days to ? 18 Years of Age.) With High-Risk Hematopoietic Stem Cell Tran

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematopoietic stem cell transplant (HSCT).

Read more